Beyond Belviq: The Real Promise in Arena Pharmaceticals’ Pipeline
Arena struggled with its obesity drug Belviq, but at a recent conference, Arena said it planned on turning its focus to its pipeline full of GPCRs. Is there hope for this company going forward?
This podcast was recorded on Mar. 10, 2016.